<DOC>
<DOCNO>en.15.121.405.2009.4.28</DOCNO>
<TITLE> Pfizer profit beats forecast </TITLE>
<TEXT>
 NEW YORK, Tue Apr 28, (bdnews24.com/Reuters) - Pfizer Inc reported a better-than-expected first-quarter profit on Tuesday, as cost-cutting helped offset sharply lower sales of its Lipitor cholesterol fighter and its Chantix smoking-cessation drug. The world's largest drugmaker earned $2.73 billion, or 40 cents per share. That compared with $2.78 billion, or 41 cents per share, in the year-ago quarter, when Pfizer took acquisition-related charges. Excluding special items, Pfizer earned 54 cents per share. Analysts on average expected 49 cents per share, according to Reuters Estimates. Company global revenue fell 8 percent to $10.87 billion, about $180 million below Wall Street expectations. Revenue would have fallen only 3 percent if not for the strengthening dollar, which lowers the value of overseas sales when converted back into US curr
</TEXT>
</DOC>
